Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Endoscopy | Research

Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis

Authors: Zefeng Zhang, Xiaoguang Zhang

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Objectives

To explore the prevalence, characteristics, age distribution and etiology changes of chronic atrophic gastritis (CAG) in South China.

Methods

This study included all patients who underwent endoscopy examinations from 2011 to 2020 in our hospital. Patients were divided into groups 1 (2011–2015) and 2 (2016–2020). The prevalence, characteristics, age distribution and etiology changes of CAG were compared between groups.

Results

Overall CAG prevalence was 20.92% (24,084/115,110) from 2011 to 2020; prevalence significantly differed between groups (18.78%, 8468/45,087, in group 1 and 22.30%, 15,616/70,023, in group 2). Patients with CAG had significantly younger age (under 45) and more corpus atrophy and more autoimmune atrophic gastritis (AAG) in group 2 than in group 1. AAG prevalence in group 2 was 30.11% (4702/15,616) significantly higher than 13.57% (1149/8468) in group 1. 82 patients with AAG later exhibited gastric cancer without obvious clinical features over the decade.

Conclusions

CAG is increasing and seems starting earlier among people during the study period. We need to focus on diagnosis and treatment of corpus related atrophy and AAG, especially for the young. Laboratory examination, endoscopic biopsy and surveillance are important for CAG.
Literature
1.
go back to reference Bai Y, Li ZS, Zou DW, et al. Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: an endoscopic database review of 102 665 patients from 1996 to 2006. Gut. 2010;59:722–8.CrossRefPubMed Bai Y, Li ZS, Zou DW, et al. Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: an endoscopic database review of 102 665 patients from 1996 to 2006. Gut. 2010;59:722–8.CrossRefPubMed
2.
go back to reference Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347–53.CrossRef Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347–53.CrossRef
3.
go back to reference Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMed Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMed
4.
go back to reference De Vries AC, Van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterol. 2008;134:945–52.CrossRef De Vries AC, Van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterol. 2008;134:945–52.CrossRef
5.
go back to reference Muhsen K, Sinnreich R, Merom D, et al. Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a crosssectional study. BMJ Open. 2019;9: e024689.CrossRefPubMedPubMedCentral Muhsen K, Sinnreich R, Merom D, et al. Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a crosssectional study. BMJ Open. 2019;9: e024689.CrossRefPubMedPubMedCentral
7.
go back to reference Chinese Society of Gastroenterology. Consensus on chronic gastritis in China in2017. Chin J Dig. 2017;37:721–38. Chinese Society of Gastroenterology. Consensus on chronic gastritis in China in2017. Chin J Dig. 2017;37:721–38.
8.
go back to reference Park YM, Kim JH, Baik SJ, et al. Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: an individualized consideration of the risk factors. Medicine (Baltimore). 2016;95: e5351.CrossRefPubMed Park YM, Kim JH, Baik SJ, et al. Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: an individualized consideration of the risk factors. Medicine (Baltimore). 2016;95: e5351.CrossRefPubMed
9.
go back to reference Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351: h3867.CrossRefPubMedPubMedCentral Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351: h3867.CrossRefPubMedPubMedCentral
10.
go back to reference Lahner E, Conti L, Annibale B, et al. Current perspectives in atrophic gastritis. Curr Gastroenterol Rep. 2020;22(8):38.CrossRefPubMed Lahner E, Conti L, Annibale B, et al. Current perspectives in atrophic gastritis. Curr Gastroenterol Rep. 2020;22(8):38.CrossRefPubMed
12.
go back to reference Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol. 2012;18:1279–85.CrossRefPubMedPubMedCentral Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol. 2012;18:1279–85.CrossRefPubMedPubMedCentral
13.
go back to reference Lahner E, Zagari RM, Zullo A, et al. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019;51(12):1621–32.CrossRefPubMed Lahner E, Zagari RM, Zullo A, et al. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019;51(12):1621–32.CrossRefPubMed
14.
15.
go back to reference Lenti MV, Miceli E, Cococcia S, et al. Determinants of diagnostic delay in autoimmune atrophic gastritis. Aliment Pharmacol Ther. 2019;50(2):167–75.CrossRefPubMed Lenti MV, Miceli E, Cococcia S, et al. Determinants of diagnostic delay in autoimmune atrophic gastritis. Aliment Pharmacol Ther. 2019;50(2):167–75.CrossRefPubMed
16.
go back to reference Lahner E, Dilaghi E, Cingolani S, et al. Gender-sex differences in autoimmune atrophic gastritis. Transl Res. 2022;248:1–10.CrossRefPubMed Lahner E, Dilaghi E, Cingolani S, et al. Gender-sex differences in autoimmune atrophic gastritis. Transl Res. 2022;248:1–10.CrossRefPubMed
17.
go back to reference Zilli A, Cavalcoli F, Ciafardini C, et al. Deficiency of micronutrients in patients affected by chronic atrophic autoimmune gastritis: a single-institution observational study. Dig Liver Dis. 2019;51(4):505–9.CrossRefPubMed Zilli A, Cavalcoli F, Ciafardini C, et al. Deficiency of micronutrients in patients affected by chronic atrophic autoimmune gastritis: a single-institution observational study. Dig Liver Dis. 2019;51(4):505–9.CrossRefPubMed
18.
go back to reference Cavalcoli F, Zilli A, Conte D, et al. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: a review. World J Gastroenterol. 2017;23(4):563–72.CrossRefPubMedPubMedCentral Cavalcoli F, Zilli A, Conte D, et al. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: a review. World J Gastroenterol. 2017;23(4):563–72.CrossRefPubMedPubMedCentral
19.
go back to reference Massironi S, Cavalcoli F, Zilli A, et al. Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study. BMC Gastroenterol. 2018;18(1):172.CrossRefPubMedPubMedCentral Massironi S, Cavalcoli F, Zilli A, et al. Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study. BMC Gastroenterol. 2018;18(1):172.CrossRefPubMedPubMedCentral
20.
go back to reference Lenti MV, Lahner E, Bergamaschi G, et al. Cell blood count alterations and patterns of anaemia in autoimmune atrophic gastritis at diagnosis: a multicentre study. J Clin Med. 2019;8(11):1992.CrossRefPubMedPubMedCentral Lenti MV, Lahner E, Bergamaschi G, et al. Cell blood count alterations and patterns of anaemia in autoimmune atrophic gastritis at diagnosis: a multicentre study. J Clin Med. 2019;8(11):1992.CrossRefPubMedPubMedCentral
21.
go back to reference Conti L, Lenti MV, Di Sabatino A, et al. Seronegative autoimmune atrophic gastritis is more common in elderly patients. Dig Liver Dis. 2020;52(11):1310–4.CrossRefPubMed Conti L, Lenti MV, Di Sabatino A, et al. Seronegative autoimmune atrophic gastritis is more common in elderly patients. Dig Liver Dis. 2020;52(11):1310–4.CrossRefPubMed
22.
go back to reference Massironi S, Zilli A, Elvevi A, et al. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18(3):215–22.CrossRefPubMed Massironi S, Zilli A, Elvevi A, et al. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18(3):215–22.CrossRefPubMed
23.
go back to reference Lenti MV, Miceli E, Vanoli A, et al. Time course and risk factors of evolution from potential to overt autoimmune gastritis. Dig Liver Dis. 2022;54(5):642–4.CrossRefPubMed Lenti MV, Miceli E, Vanoli A, et al. Time course and risk factors of evolution from potential to overt autoimmune gastritis. Dig Liver Dis. 2022;54(5):642–4.CrossRefPubMed
24.
go back to reference Ribaldone DG, Simondi D, Petrini E, et al. Non-invasive biomarkers for gastric cancer diagnosis: Ready for prime time? Minerva Biotecnologica. 2019;31:3–10.CrossRef Ribaldone DG, Simondi D, Petrini E, et al. Non-invasive biomarkers for gastric cancer diagnosis: Ready for prime time? Minerva Biotecnologica. 2019;31:3–10.CrossRef
25.
go back to reference Esposito G, Dilaghi E, Cazzato M, et al. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region. Dig Liver Dis. 2021;53(4):467–73.CrossRefPubMed Esposito G, Dilaghi E, Cazzato M, et al. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region. Dig Liver Dis. 2021;53(4):467–73.CrossRefPubMed
26.
go back to reference Miceli E, Vanoli A, Lenti MV, et al. Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience. Aliment Pharmacol Ther. 2019;50(11–12):1172–80.CrossRefPubMed Miceli E, Vanoli A, Lenti MV, et al. Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience. Aliment Pharmacol Ther. 2019;50(11–12):1172–80.CrossRefPubMed
27.
go back to reference Rugge M, Bricca L, Guzzinati S, et al. Autoimmune gastritis: long-term natural history in naïve <i>Helicobacter pylori</i>-negative patients. Gut. 2023;72(1):30–8.CrossRefPubMed Rugge M, Bricca L, Guzzinati S, et al. Autoimmune gastritis: long-term natural history in naïve <i>Helicobacter pylori</i>-negative patients. Gut. 2023;72(1):30–8.CrossRefPubMed
Metadata
Title
Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis
Authors
Zefeng Zhang
Xiaoguang Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02662-1

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.